ask="58.87"
ask_size="500"
average_daily_volume="393016"
bid="49.58"
bid_size="100"
book_value="14.89"
change="+0.42"
change_from_200_day_moving_average="2.60"
change_from_50_day_moving_average="-1.78"
change_from_52_week_high="-8.83"
change_From_52_week_low="24.14"
change_in_percent="+0.81%"
close="52.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="23997000"
high="52.98"
high_52_weeks="60.98"
last_trade_date="1/9/2017"
last_trade_price="52.15"
last_trade_size="42520"
last_trade_time="4:00pm"
low="50.72"
low_52_weeks="28.01"
market_capitalization="1.42B"
moving_average_200_day="49.55"
moving_average_50_day="53.93"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="52.18"
pe_ratio="5.83"
peg_ratio="0.38"
percent_change_from_200_day_moving_average="+5.24%"
percent_change_from_50_day_moving_average="-3.31%"
percent_change_from_52_week_high="-14.48%"
percent_change_from_52_week_low="+86.18%"
previous_close="51.73"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.48"
price_per_sales="3.64"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.50"
stock_exchange="NMS"
symbol="FPRX"
volume="348857"
weeks_range_52="28.01 - 60.98"
